Nuclear Matrix Protein p84 Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F2246-20UL

Regular price €199,00 EUR
Regular price Sale price €199,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

The nuclear matrix protein p84, also known as THOC1, serves as a critical binding partner for the amino-terminal region of the retinoblastoma (RB) protein, specifically in its hypophosphorylated, growth-suppressive state. This interaction is vital as p84 is primarily localized in subnuclear regions involved in RNA processing and transcription, enabling it to anchor RB to these functionally active nuclear domains.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following Nuclear Matrix Protein p84 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

Nuclear Matrix Protein p84 is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cytoplasm and nucleus across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • co-patterning with orthogonal markers and control conditions that clarify pathway state
  • time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for Nuclear Matrix Protein p84. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in Nuclear Matrix Protein p84 reflect biology rather than handling. When interpreting Nuclear Matrix Protein p84, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep Nuclear Matrix Protein p84 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
Nuclear Matrix Protein P84
Research Area:
Cancer
Application:
FCM • IF • IHC • IP • WB
Reactivity:
Human • Mouse • Rat
Specificity:
Nuclear Matrix Protein p84 Antibody [L4N18] recognizes endogenous levels of total Nuclear Matrix Protein p84 protein.
Host:
Mouse
Clonality:
Monoclonal
Clone:
L4N18
UniProt:
Q96FV9
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.